HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhenghong Yu Selected Research

Mitogen-Activated Protein Kinases

12/2019ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhenghong Yu Research Topics

Disease

13Neoplasms (Cancer)
01/2023 - 07/2004
8Breast Neoplasms (Breast Cancer)
12/2023 - 01/2013
3Stomach Neoplasms (Stomach Cancer)
07/2023 - 08/2020
2Critical Illness (Critically Ill)
01/2022 - 01/2021
2Lung Neoplasms (Lung Cancer)
12/2015 - 05/2007
1Glioma (Gliomas)
11/2022
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
08/2021
1Malnutrition (Nutritional Deficiencies)
01/2021
1Pain (Aches)
12/2019
1Osteosarcoma (Osteogenic Sarcoma)
06/2019
1Intervertebral Disc Degeneration
01/2018
1Triple Negative Breast Neoplasms
01/2017
1Congenital Abnormalities (Deformity)
01/2016
1Hepatitis B
01/2016
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Inflammation (Inflammations)
01/2016
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Tuberculosis (Tuberculoses)
01/2016
1Spinal Tuberculosis (Pott's Disease)
01/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
12/2015
1Adenocarcinoma of Lung
12/2015
1Prostatic Neoplasms (Prostate Cancer)
07/2004

Drug/Important Bio-Agent (IBA)

4Biomarkers (Surrogate Marker)IBA
12/2023 - 05/2007
3Interleukin-2 (IL2)IBA
01/2022 - 01/2021
3Interleukin-8 (Interleukin 8)IBA
01/2022 - 01/2021
3CytokinesIBA
08/2021 - 01/2018
3Proteins (Proteins, Gene)FDA Link
02/2020 - 06/2015
3DNA (Deoxyribonucleic Acid)IBA
01/2016 - 07/2004
2Messenger RNA (mRNA)IBA
11/2022 - 12/2015
2RNA (Ribonucleic Acid)IBA
11/2022 - 12/2019
2Interleukin-6 (Interleukin 6)IBA
01/2022 - 01/2021
2ProcalcitoninIBA
01/2022 - 08/2021
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2021
2protein kinase C nuIBA
01/2021 - 01/2017
2Estrogen ReceptorsIBA
02/2020 - 06/2015
2TamoxifenFDA LinkGeneric
02/2020 - 01/2017
2Estrogens (Estrogen)FDA Link
06/2015 - 01/2013
1Prokaryotic Initiation Factor-2IBA
12/2023
1AntigensIBA
12/2022
1Cell Adhesion MoleculesIBA
11/2022
1Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1C-Reactive ProteinIBA
08/2021
1InterleukinsIBA
08/2021
1Lysine (L-Lysine)FDA Link
08/2020
1Histones (Histone)IBA
08/2020
1Histone MethyltransferasesIBA
08/2020
1Histone-Lysine N-MethyltransferaseIBA
08/2020
1SincalideFDA Link
02/2020
1Mitogen-Activated Protein KinasesIBA
12/2019
1Phenobarbital (Luminal)FDA Link
12/2019
1Phosphotransferases (Kinase)IBA
12/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2019
1Immune Checkpoint InhibitorsIBA
06/2019
1AntibodiesIBA
06/2019
1acetamideIBA
06/2019
1Protein Kinase D2IBA
01/2019
1Peptide Hydrolases (Proteases)FDA Link
01/2018
1Histone Deacetylase 6IBA
01/2017
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017
1tubacinIBA
01/2017
117- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
01/2017
1Sorafenib (BAY 43-9006)FDA Link
01/2016
1Antiviral Agents (Antivirals)IBA
01/2016
1Cisplatin (Platino)FDA LinkGeneric
12/2015
1Pemetrexed (MTA)FDA Link
12/2015
1crocinIBA
12/2015
1Aromatase InhibitorsIBA
06/2015
1ProgesteroneFDA LinkGeneric
06/2015
1Glycoproteins (Glycoprotein)IBA
02/2015
1Complementary DNA (cDNA)IBA
01/2013
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2013

Therapy/Procedure

6Therapeutics
01/2023 - 02/2015
2Gastrectomy
07/2023 - 06/2023
1Drug Therapy (Chemotherapy)
11/2022
1Nutritional Support (Artificial Feeding)
01/2021
1Injections
12/2019
1Pedicle Screws
01/2016
1Debridement
01/2016
1Hepatectomy
01/2016
1Liver Transplantation
01/2016